BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27184028)

  • 1. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem-cell challenges in the treatment of Alzheimer's disease: a long way from bench to bedside.
    Fan X; Sun D; Tang X; Cai Y; Yin ZQ; Xu H
    Med Res Rev; 2014 Sep; 34(5):957-78. PubMed ID: 24500883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
    Si Z; Wang X
    J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent approaches and challenges in iPSCs: modeling and cell-based therapy of Alzheimer's disease.
    Csöbönyeiová M; Polák Š; Danišovič L
    Rev Neurosci; 2016 Jul; 27(5):457-64. PubMed ID: 26812864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Being human: The role of pluripotent stem cells in regenerative medicine and humanizing Alzheimer's disease models.
    Sproul AA
    Mol Aspects Med; 2015; 43-44():54-65. PubMed ID: 26101165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease.
    Xu Y; Wang S; Zhu P
    Curr Stem Cell Res Ther; 2023; 18(2):154-162. PubMed ID: 35473516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Patient-Derived Induced Pluripotent Stem Cells for Alzheimer's Disease Modeling.
    Lee C; Willerth SM; Nygaard HB
    Prog Neurobiol; 2020 Sep; 192():101804. PubMed ID: 32464173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human iPSC application in Alzheimer's disease and Tau-related neurodegenerative diseases.
    Tcw J
    Neurosci Lett; 2019 Apr; 699():31-40. PubMed ID: 30685408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cell Technology: A Paradigm Shift in Medical Science for Drug Screening and Disease Modeling.
    Nair M; Sandhu SS; Sharma AK
    Curr Med Chem; 2017; 24(39):4368-4398. PubMed ID: 28748763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient-derived iPSCs, a reliable
    Amponsah AE; Guo R; Kong D; Feng B; He J; Zhang W; Liu X; Du X; Ma Z; Liu B; Ma J; Cui H
    Rev Neurosci; 2021 Jun; 32(4):379-402. PubMed ID: 33550785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human-induced pluripotent stem cells as a model for studying sporadic Alzheimer's disease.
    Riemens RJM; Kenis G; van den Beucken T
    Neurobiol Learn Mem; 2020 Nov; 175():107318. PubMed ID: 32977028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
    Atkinson-Dell R; Mohamet L
    Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease.
    Sullivan SE; Young-Pearse TL
    Brain Res; 2017 Feb; 1656():98-106. PubMed ID: 26459988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells (iPSCs): the emergence of a new champion in stem cell technology-driven biomedical applications.
    Das AK; Pal R
    J Tissue Eng Regen Med; 2010 Aug; 4(6):413-21. PubMed ID: 20084623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.